» Articles » PMID: 27597964

Differential Regulatory Analysis Based on Coexpression Network in Cancer Research

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2016 Sep 7
PMID 27597964
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

With rapid development of high-throughput techniques and accumulation of big transcriptomic data, plenty of computational methods and algorithms such as differential analysis and network analysis have been proposed to explore genome-wide gene expression characteristics. These efforts are aiming to transform underlying genomic information into valuable knowledges in biological and medical research fields. Recently, tremendous integrative research methods are dedicated to interpret the development and progress of neoplastic diseases, whereas differential regulatory analysis (DRA) based on gene coexpression network (GCN) increasingly plays a robust complement to regular differential expression analysis in revealing regulatory functions of cancer related genes such as evading growth suppressors and resisting cell death. Differential regulatory analysis based on GCN is prospective and shows its essential role in discovering the system properties of carcinogenesis features. Here we briefly review the paradigm of differential regulatory analysis based on GCN. We also focus on the applications of differential regulatory analysis based on GCN in cancer research and point out that DRA is necessary and extraordinary to reveal underlying molecular mechanism in large-scale carcinogenesis studies.

Citing Articles

A collaborative network analysis for the interpretation of transcriptomics data in Huntington's disease.

Ozisik O, Kara N, Abbassi-Daloii T, Terezol M, Kuijper E, Queralt-Rosinach N Sci Rep. 2025; 15(1):1412.

PMID: 39789061 PMC: 11718016. DOI: 10.1038/s41598-025-85580-4.


Single-Sample Networks Reveal Intra-Cytoband Co-Expression Hotspots in Breast Cancer Subtypes.

Ponce-Cusi R, Lopez-Sanchez P, Maracaja-Coutinho V, Espinal-Enriquez J Int J Mol Sci. 2024; 25(22).

PMID: 39596229 PMC: 11594411. DOI: 10.3390/ijms252212163.


Signaling networks in inflammatory pathways and risk for suicidal behavior.

Rengasamy M, Zhong Y, Marsland A, Chen K, Douaihy A, Brent D Brain Behav Immun Health. 2021; 7.

PMID: 33791683 PMC: 8009526. DOI: 10.1016/j.bbih.2020.100122.


Transcriptome differences in adipose stromal cells derived from pre- and postmenopausal women.

Xie Y, Fang B, Liu W, Li G, Huang R, Zhang L Stem Cell Res Ther. 2020; 11(1):92.

PMID: 32111240 PMC: 7049195. DOI: 10.1186/s13287-020-01613-x.


Differential regulatory network-based quantification and prioritization of key genes underlying cancer drug resistance based on time-course RNA-seq data.

Zhang J, Zhu W, Wang Q, Gu J, Huang L, Sun X PLoS Comput Biol. 2019; 15(11):e1007435.

PMID: 31682596 PMC: 6827891. DOI: 10.1371/journal.pcbi.1007435.


References
1.
Liu Y, Zhao M . lnCaNet: pan-cancer co-expression network for human lncRNA and cancer genes. Bioinformatics. 2016; 32(10):1595-7. DOI: 10.1093/bioinformatics/btw017. View

2.
Liu B, Yu H, Tu K, Li C, Li Y, Li Y . DCGL: an R package for identifying differentially coexpressed genes and links from gene expression microarray data. Bioinformatics. 2010; 26(20):2637-8. PMC: 2951087. DOI: 10.1093/bioinformatics/btq471. View

3.
Wu J, Zhao X, Lin Z, Shao Z . A system level analysis of gastric cancer across tumor stages with RNA-seq data. Mol Biosyst. 2015; 11(7):1925-32. DOI: 10.1039/c5mb00105f. View

4.
Schadt E . Molecular networks as sensors and drivers of common human diseases. Nature. 2009; 461(7261):218-23. DOI: 10.1038/nature08454. View

5.
Inamura K, Fujiwara T, Hoshida Y, Isagawa T, Jones M, Virtanen C . Two subclasses of lung squamous cell carcinoma with different gene expression profiles and prognosis identified by hierarchical clustering and non-negative matrix factorization. Oncogene. 2005; 24(47):7105-13. DOI: 10.1038/sj.onc.1208858. View